The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in the US, and it is expected to be the second leading cause of cancer deaths by 2030. The lack of effective early screening tests and alarming symptoms with early undetectable micro-metastasis at the time of presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsayed, Marwa, Abdelrahim, Maen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067364/
https://www.ncbi.nlm.nih.gov/pubmed/33917380
http://dx.doi.org/10.3390/biomedicines9040389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067364/
https://www.ncbi.nlm.nih.gov/pubmed/33917380
http://dx.doi.org/10.3390/biomedicines9040389

Ejemplares similares